Recombinant Lactococcus lactis subsp. cremoris Aminopeptidase N (pepN), partial

What is Aminopeptidase N (PepN) and what is its role in Lactococcus lactis?

Aminopeptidase N (PepN) is a 95-kDa intracellular enzyme that plays a crucial role in the proteolytic system of Lactococcus lactis. The enzyme demonstrates lysyl-aminopeptidase activity, meaning it can cleave amino acids from the N-terminus of peptides, with preference for lysine residues. PepN contributes to the hydrolysis of peptides derived from casein during cheese ripening and is encoded by the chromosomal pepN gene. Research has confirmed its intracellular localization through immunogold labeling techniques, and sequencing analysis has demonstrated that the amino terminus lacks signal sequence characteristics, further confirming its intracellular nature .

How can the pepN gene be identified and isolated from Lactococcus lactis?

The pepN gene can be identified using a comprehensive approach involving:

• Library construction: Create a genomic library (e.g., lambda EMBL3 library) of L. lactis DNA in E. coli

• Immunological screening: Screen the library using antiserum raised against purified aminopeptidase fractions

• Hybridization: Use mixed-oligonucleotide probes designed from known N-terminal amino acid sequences

• Functional complementation: Verify by complementing E. coli strains carrying mutations in their pepN gene

This methodology has been successfully employed by researchers who identified, localized, and subcloned the pepN gene in E. coli based on its expression and hybridization patterns . Once identified, PCR amplification with specific primers designed from the known sequence regions can be used for routine isolation.

What expression systems are most effective for recombinant PepN production in Lactococcus lactis?

Several expression systems have demonstrated efficacy for recombinant protein production in L. lactis, with the P170 expression system showing particularly promising results. This system utilizes the P170 promoter, which is naturally upregulated as lactate accumulates in the growth medium during bacterial fermentation.

For optimal PepN expression, researchers should consider:

• Promoter selection: Enhanced P170 promoter variants show improved strength

• Signal peptide optimization: For intracellular retention (as needed for PepN)

• Production strain selection: Strains with increased productivity are available

• Growth medium formulation: Animal-derived component-free media for simple batch fermentation

When employing the P170 system, the main limitation is growth inhibition due to lactate accumulation. This can be addressed by combining the P170 expression system with electrodialysis technologies like REED, which controls lactate concentration during fermentation. Studies using this approach have achieved production levels of up to 2.5 g/L for certain recombinant proteins, demonstrating the potential for high-yield production of enzymes like PepN .

How can recombinant PepN expression be optimized for enhanced proteolytic activity in cheese ripening?

Optimization of recombinant PepN expression for cheese ripening applications requires a multifaceted approach focusing on:

• Source selection: PepN genes from highly proteolytic strains like Lactobacillus helveticus often yield enzymes with enhanced activity compared to native L. lactis pepN

• Vector selection: Food-grade cloning systems are essential for dairy applications

• Enzymatic activity assessment: Peptidase activities must be evaluated under conditions mimicking maturing cheese (low pH, high salt, reduced water activity)

• Comparative analysis: Relative activities from transformants versus untransformed hosts should be systematically measured

Studies have demonstrated that introducing selected peptidase genes from Lactobacillus helveticus into L. lactis can significantly increase peptidase activity, contributing to improved proteolysis during cheese maturation. This targeted approach enables the development of starter strains with enhanced capabilities for shortening ripening periods and improving characteristics of specialty cheeses, including reduced-fat varieties that typically present ripening challenges .

What methodology should be used to assess the cellular localization of PepN in Lactococcus lactis?

Determining the cellular localization of PepN requires multiple complementary approaches:

• Sequence analysis:

  • Examine the N-terminal region for signal peptide characteristics using prediction algorithms

  • Compare the deduced amino acid sequence with the determined amino-terminal sequence

• Immunological methods:

  • Immunogold labeling: Fix bacterial cells, embed in resin, section, and label with anti-PepN antibodies followed by gold-conjugated secondary antibodies

  • Visualization by transmission electron microscopy to identify the precise subcellular location

• Cellular fractionation:

  • Separate cell wall, membrane, and cytoplasmic fractions using differential centrifugation

  • Measure enzyme activity in each fraction using specific substrates (e.g., Lys-pNA)

  • Perform western blotting with anti-PepN antibodies on each fraction

Research has conclusively demonstrated through these approaches that PepN lacks characteristics of consensus signal sequences and does not undergo post-translational processing of its amino terminus. Immunogold labeling has confirmed the intracellular localization of aminopeptidase N in L. lactis cells, an important consideration when designing expression systems .

How can recombinant L. lactis strains expressing PepN be applied in therapeutic contexts?

Recombinant L. lactis strains have shown significant potential as delivery vehicles for therapeutic proteins, including those targeting inflammatory and cancer conditions. For PepN-expressing strains or other therapeutic proteins, the methodology involves:

• Vector construction:

  • Selection of appropriate expression cassettes (e.g., pExu vector system)

  • Incorporation of the target gene under a suitable promoter

• Delivery assessment:

  • In vitro evaluation using cell lines relevant to the target condition

  • Ex vivo testing using organoids derived from patient tissues

  • In vivo testing in appropriate animal models (e.g., DSS-induced colitis)

• Therapeutic evaluation parameters:

  • Clinical parameters (weight, disease activity index)

  • Histological assessment (tissue damage, cell counts)

  • Molecular markers (gene expression of inflammatory cytokines)

  • Physiological parameters (enzyme activities like MPO)

Recent studies have demonstrated that recombinant L. lactis strains expressing therapeutic proteins can protect intestinal mucosa and mitigate inflammatory damage. For example, L. lactis expressing the p62 protein showed protective effects in DSS-induced colitis models, reducing pro-inflammatory cytokines TNF and IFN-γ while increasing goblet cell counts and MUC2 expression . Similar approaches could be utilized for PepN if therapeutic applications are identified.

What methodologies are recommended for analyzing the enzymatic properties of recombinant PepN?

A comprehensive characterization of recombinant PepN enzymatic properties should include:

• Substrate specificity analysis:

  • Test various chromogenic/fluorogenic substrates (e.g., Lys-pNA, Arg-pNA)

  • Determine kinetic parameters (Km, Vmax, kcat) for each substrate

  • Assess activity on different peptide lengths and compositions

• Biochemical characterization:

  • pH optimum and stability profiles (pH 4.0-9.0)

  • Temperature optimum and thermal stability (4-60°C)

  • Effects of metal ions (Zn2+, Ca2+, Mg2+) and chelating agents (EDTA)

  • Inhibitor sensitivity (bestatin, PMSF, iodoacetamide)

• Stability assessment under cheese-ripening conditions:

  • Low pH (5.0-5.5)

  • High salt concentration (4-5% NaCl)

  • Low water activity

  • Extended incubation periods (weeks to months)

• Comparative analysis with PepN from other sources:

  • Direct comparison with native PepN from L. lactis

  • Comparison with other aminopeptidases from lactobacilli

The enzymatic analysis should be performed with purified enzyme preparations, obtained through techniques such as affinity chromatography or ion exchange chromatography followed by gel filtration .

How can researchers effectively purify recombinant PepN for structural studies?

Purification of recombinant PepN for structural studies requires a multi-step approach to achieve the high purity necessary:

• Expression optimization:

  • High-level expression systems (e.g., T7 system in E. coli or optimized P170 system in L. lactis)

  • Induction conditions optimization (temperature, time, inducer concentration)

  • Addition of affinity tags if compatible with structural studies

• Cell disruption methods:

  • For L. lactis: Glass bead disruption or enzymatic lysis (lysozyme with mutanolysin)

  • For E. coli: Sonication or high-pressure homogenization

• Purification protocol:

  • Initial clarification: Centrifugation (15,000 × g, 30 min)

  • Ammonium sulfate fractionation (30-60% saturation)

  • Ion exchange chromatography (DEAE-Sepharose)

  • Hydrophobic interaction chromatography

  • Size exclusion chromatography as a polishing step

• Quality assessment:

  • SDS-PAGE analysis (>95% purity)

  • Western blotting with anti-PepN antibodies

  • Mass spectrometry for identity confirmation

  • Dynamic light scattering for homogeneity assessment

  • Activity assays to confirm functional integrity

For crystallography studies, additional steps may include buffer optimization through thermal shift assays and limited proteolysis to identify stable domains. Researchers have successfully visualized the overproduction of 95-kDa aminopeptidase N on SDS-polyacrylamide gels and immunoblots following high-level expression in E. coli using the T7 system .

What are the best approaches for comparing the activity of recombinant PepN variants across different Lactococcus and Lactobacillus species?

Comparing PepN variants across different species requires standardized methodologies:

• Sequence and phylogenetic analysis:

  • Multiple sequence alignment of pepN genes from various species

  • Identification of conserved domains and catalytic residues

  • Construction of phylogenetic trees to establish evolutionary relationships

• Heterologous expression:

  • Expression of different pepN variants in a common host (E. coli or L. lactis)

  • Standardized expression conditions and vector systems

  • Verification of expression levels by Western blotting

• Standardized activity assays:

  • Common substrates (Lys-pNA as primary substrate)

  • Normalized enzyme concentrations

  • Defined reaction conditions (pH, temperature, buffer composition)

  • Calculation of specific activities (μmol product/min/mg protein)

• Cheese-relevant conditions testing:

  • Activity in simulated cheese environments

  • Peptide profile analysis using HPLC or LC-MS/MS

  • Comparative proteolysis assessment in experimental cheese models

This approach allows researchers to directly compare enzymatic properties and identify species-specific characteristics that may be advantageous for particular applications. Studies comparing pepN from L. lactis with peptidases from Lactobacillus helveticus have demonstrated significant differences in activity profiles under cheese-ripening conditions, with implications for their effectiveness in accelerating cheese maturation .

How can researchers effectively monitor recombinant PepN activity in cheese models?

Monitoring recombinant PepN activity in cheese models requires specialized approaches that accommodate the complex cheese matrix:

• Peptide profiling techniques:

  • Water-soluble peptide extraction from cheese

  • Reversed-phase HPLC analysis

  • Mass spectrometry (LC-MS/MS) for peptide identification

  • Monitoring specific peptides known to be PepN substrates

• Specific activity measurements:

  • Design of extraction protocols to recover active enzymes from cheese

  • Fluorogenic or chromogenic substrate assays adapted for cheese extracts

  • Controls with specific inhibitors to confirm PepN contribution

• Comparative proteolysis assessment:

  • Comparison between cheeses made with recombinant vs. control strains

  • Nitrogen fractionation analysis (TCA-soluble nitrogen, PTA-soluble nitrogen)

  • Free amino acid analysis by HPLC

• Sensory correlation:

  • Correlation between measured enzymatic activities and sensory properties

  • Taste compound identification (particularly bitter peptides degradation)

Research has shown that introducing peptidase genes from Lactobacillus helveticus into L. lactis can significantly enhance peptidolytic enzyme activity under cheese maturation conditions, contributing to accelerated ripening and improved characteristics of specialty cheeses .

What are the critical control points when designing expression systems for PepN in food-grade L. lactis strains?

Designing food-grade expression systems for PepN in L. lactis requires attention to several critical control points:

• Vector design requirements:

  • Absence of antibiotic resistance markers (use food-grade selection markers instead)

  • Origin of replication from food-grade sources

  • All vector components derived from GRAS (Generally Recognized As Safe) organisms

• Promoter selection considerations:

  • Food-grade inducible promoters (e.g., P170 responsive to lactate accumulation)

  • Constitutive promoters with appropriate strength for desired expression level

  • Avoidance of toxic or allergen-encoding sequences

• Expression level optimization:

  • Balance between high expression and metabolic burden

  • Optimization of codon usage for L. lactis

  • Avoidance of detrimental effects on starter culture functionality

• Stability considerations:

  • Plasmid stability during extended fermentation periods

  • Genetic stability during cheese manufacturing and ripening

  • Prevention of horizontal gene transfer

• Regulatory compliance:

  • Documentation of all genetic elements and their sources

  • Absence of transferable antibiotic resistance genes

  • Compliance with food safety regulations

The P170 expression system has been optimized for recombinant protein production in L. lactis through improvements in promoter strength, signal peptides, and isolation of production strains with increased productivity. This system utilizes a growth medium with no animal-derived components and requires minimal process control, making it suitable for food applications .

How do researchers evaluate the safety and efficacy of recombinant L. lactis strains expressing PepN for potential health applications?

Evaluating safety and efficacy of recombinant L. lactis strains for health applications involves a systematic approach:

• In vitro safety assessment:

  • Antibiotic susceptibility testing

  • Detection of potential virulence factors

  • Assessment of horizontal gene transfer potential

  • Production of undesirable metabolites (biogenic amines, etc.)

• In vivo safety studies:

  • Acute toxicity assessment in animal models

  • Subchronic administration studies

  • Monitoring of inflammatory markers and tissue histology

  • Assessment of bacteria persistence and translocation

• Efficacy evaluation protocol:

  • Selection of appropriate disease models (e.g., DSS-induced colitis)

  • Measurement of clinical parameters (weight, disease activity index)

  • Analysis of molecular markers (cytokine expression profiles)

  • Histological assessment (tissue integrity, cell populations)

• Microbiome impact assessment:

  • 16S rRNA gene sequencing for microbiota composition analysis

  • Alpha and beta diversity measurements

  • Specific bacterial population monitoring

Recent studies with recombinant L. lactis expressing therapeutic proteins have demonstrated effectiveness in animal models of inflammatory conditions. For example, L. lactis delivering the p62 protein protected intestinal mucosa and mitigated inflammatory damages in DSS-induced colitis, despite showing no significant impact on intestinal microbiota diversity . Similar methodologies could be applied to assess PepN-expressing strains in relevant health applications.

What experimental designs are most appropriate for testing recombinant L. lactis strains in colorectal cancer models?

Testing recombinant L. lactis strains in colorectal cancer models requires robust experimental designs:

• Model selection:

  • Genetic models: APC min/+ mice (transgenic CRC model)

  • Chemical induction models: Azoxymethane (AOM) with DSS

  • Patient-derived xenograft models for human relevance

• Treatment protocols:

  • Preventive approach: Administration before cancer induction

  • Therapeutic approach: Administration after tumor establishment

  • Dosage optimization: Typically 10^9 CFU/day (freshly prepared)

  • Administration route: Oral gavage for precise dosing

• Evaluation parameters:

  • Tumor number and size measurements

  • Histopathological analysis of tissue sections

  • Proliferation markers (Ki67, PCNA)

  • Apoptosis markers (TUNEL assay, cleaved caspase-3)

  • Inflammatory cytokine profiles (TNF, IFN-γ, IL-17A)

  • Cell-specific markers (goblet cells, T cells)

• Mechanism investigation:

  • Conditioned medium studies to identify secreted factors

  • Molecular weight fractionation to isolate active components

  • Mass spectrometry for protein identification

  • Validation with purified recombinant proteins

Research has shown that specific L. lactis strains can suppress colorectal tumorigenesis through various mechanisms, including restoration of gut microbiota and secretion of functional proteins. For example, L. lactis HkyuLL 10 was found to reduce tumor number and size in both APC min/+ mice and AOM+DSS-treated mice models, with alpha-mannosidase identified as the functional protein responsible for anti-cancer effects4.

How can researchers troubleshoot low expression levels of recombinant PepN in Lactococcus lactis?

Troubleshooting low PepN expression in L. lactis requires systematic analysis:

• Genetic construct evaluation:

  • Verify sequence integrity (absence of mutations, correct reading frame)

  • Optimize codon usage for L. lactis

  • Check promoter strength and regulatory elements

  • Evaluate ribosome binding site efficiency

• Expression conditions optimization:

  • Test different growth phases for harvest (early vs. late exponential)

  • Optimize induction parameters (if using inducible systems)

  • Adjust fermentation parameters (pH, temperature, media composition)

  • Test different host strains (MG1363, IL1403, NZ9000)

• Protein stability assessment:

  • Evaluate proteolytic degradation by host proteases

  • Add protease inhibitors during extraction

  • Test fusion partners to enhance stability

  • Optimize cell disruption methods to preserve activity

• Detection methodology enhancement:

  • Develop sensitive activity assays for low expression detection

  • Use Western blotting with optimized antibodies

  • Consider epitope tagging for easier detection

Researchers have achieved 20-fold increases in lysyl-aminopeptidase activity through cloning of the pepN gene on multicopy plasmids in L. lactis, resulting in enzyme levels corresponding to several percent of total protein . This demonstrates the potential for high-level expression when proper optimization strategies are employed.

What advanced analytical techniques are recommended for characterizing protein-peptide interactions of recombinant PepN?

Characterizing protein-peptide interactions of recombinant PepN requires sophisticated analytical approaches:

• Binding affinity measurements:

  • Surface Plasmon Resonance (SPR) to determine association/dissociation kinetics

  • Isothermal Titration Calorimetry (ITC) for thermodynamic parameters

  • Microscale Thermophoresis (MST) for solution-based affinity measurements

• Structural analysis techniques:

  • X-ray crystallography of PepN-peptide complexes

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS)

  • Nuclear Magnetic Resonance (NMR) for binding site mapping

  • Cryo-electron microscopy for large complexes

• Computational approaches:

  • Molecular docking studies of peptide substrates

  • Molecular dynamics simulations of enzyme-substrate interactions

  • Binding free energy calculations

  • Quantitative structure-activity relationship (QSAR) models

• Substrate specificity profiling:

  • Peptide library screening (SPOT synthesis)

  • Positional scanning synthetic combinatorial libraries

  • LC-MS/MS analysis of digestion products from complex peptide mixtures

These advanced techniques provide detailed insights into the molecular basis of substrate recognition and catalysis by PepN, facilitating rational enzyme engineering for enhanced activity or altered substrate specificity. For food applications, understanding these interactions can help predict the impact of PepN on flavor development during cheese ripening through specific peptide hydrolysis patterns .

What are the most effective strategies for creating stable food-grade expression systems for PepN in L. lactis?

Creating stable food-grade expression systems for PepN requires specialized strategies:

• Selection marker alternatives:

  • Complementation of auxotrophic markers (e.g., thyA, alr, dltD)

  • Sugar utilization markers (e.g., lacF)

  • Immunity to bacteriocins (e.g., nisin immunity)

  • Dominant food-grade selectable markers (e.g., lacticin 481 resistance)

• Vector stability enhancement:

  • Integration into chromosomal loci for long-term stability

  • Use of theta-type replicons instead of rolling-circle replicons

  • Implementation of partitioning systems to ensure proper segregation

  • Reduction of metabolic burden through careful promoter selection

• Expression containment strategies:

  • Use of strictly regulated promoters

  • Implementation of genetic switches responsive to cheese-specific conditions

  • Development of self-limiting systems for biocontainment

• Process optimization for maintaining stability:

  • Fermentation parameters optimization

  • Media formulation to maintain selective pressure

  • Monitoring genetic stability during extended culture periods

The P170 expression system has been successfully optimized for recombinant protein production in L. lactis through improvements in promoter strength and production strain selection. When combined with technologies like REED for lactate control during fermentation, this system can achieve high production levels (up to 2.5 g/L for certain proteins) while maintaining stability . Similar approaches could be applied specifically for PepN expression in food applications.

How does PepN activity compare with other peptidases in the Lactococcus lactis proteolytic system?

Comparative analysis of PepN with other L. lactis peptidases reveals distinct functional relationships:

The cooperative action of these peptidases is essential for complete degradation of casein-derived peptides during cheese ripening, with each enzyme contributing to specific aspects of the proteolytic process. Understanding these relationships allows for strategic enhancement of proteolysis through targeted expression of specific peptidases.

What emerging technologies are advancing the study of recombinant peptidases in Lactococcus lactis?

Several emerging technologies are transforming research on recombinant peptidases in L. lactis:

• CRISPR-Cas genome editing:

  • Precise genomic integration of peptidase genes

  • Multiplexed modification of regulatory elements

  • Knockout of competing peptidases to channel proteolytic activity

  • Engineering of promoter sequences for optimized expression

• Systems biology approaches:

  • Multi-omics integration (transcriptomics, proteomics, metabolomics)

  • Metabolic flux analysis to understand impact on cellular metabolism

  • Genome-scale models for predicting expression optimization strategies

  • Protein-protein interaction networks to identify cofactors

• Advanced fermentation technologies:

  • High-throughput microbioreactor systems for rapid screening

  • Controlled continuous cultures with real-time monitoring

  • Electrodialysis techniques (like REED) for lactate control during fermentation

  • Scale-down models that accurately predict industrial-scale performance

• Synthetic biology tools:

  • Standardized genetic parts for L. lactis

  • Orthogonal expression systems with minimal cross-talk

  • Cell-free expression systems for rapid prototyping

  • Biosensor development for real-time monitoring of peptidase activity

The combination of the P170 expression system with REED technology has demonstrated the potential to achieve high production levels (up to 2.5 g/L) for recombinant proteins in L. lactis . These advanced technologies enable more precise control over expression systems and facilitate the development of tailored peptidase-expressing strains for specific applications in both food and therapeutic contexts.

What are the most promising future research directions for recombinant PepN applications?

Future research on recombinant PepN applications shows promising directions in several areas:

• Enzyme engineering for enhanced functionality:

  • Rational design based on structural insights

  • Directed evolution for improved activity in cheese environments

  • Development of PepN variants with altered substrate specificity

  • Creation of fusion proteins with complementary peptidases

• Advanced cheese ripening applications:

  • Development of starter cultures with balanced peptidase profiles

  • Targeted proteolysis for specific flavor development

  • Application in challenging cheese varieties (reduced-fat, low-salt)

  • PepN immobilization technologies for continuous processing

• Therapeutic applications exploration:

  • Investigation of PepN's potential in hydrolyzing bioactive peptides

  • Development of delivery systems for intestinal targeting

  • Exploration of immunomodulatory effects of specific peptides

  • Integration with other therapeutic proteins in multifunctional strains

• Novel analytical approaches:

  • Real-time monitoring of PepN activity in complex environments

  • Development of peptidomics techniques for comprehensive analysis

  • Integration of artificial intelligence for predicting peptide hydrolysis patterns

  • High-throughput screening platforms for strain optimization

Recent studies have demonstrated the potential of recombinant L. lactis strains in various applications, from cheese ripening enhancement to therapeutic protein delivery . The ability of L. lactis to deliver functional proteins like alpha-mannosidase with anti-cancer effects4 suggests that PepN or its engineered variants might also find applications beyond traditional dairy uses, particularly if they can generate bioactive peptides with specific health benefits.